Skip to main content

Dermatofibrosarcoma Protuberans News

Related terms: Cancer, Dermatofibrosarcoma Protuberans

FDA Approves Imkeldi (imatinib) Oral Solution for the Treatment of Certain Forms of Leukemia and Other Cancers

CAMBRIDGE, Mass.-- November 25, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the FDA has approved Imkeldi (imatinib) oral solution, the fir...

Ask a question

To post your own question to our community, sign in or create an account.